Shares of DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $68.33, but opened at $74.34. DiaSorin shares last traded at $74.34, with a volume of 300 shares.
Analyst Upgrades and Downgrades
Separately, Morgan Stanley upgraded shares of DiaSorin from an “underweight” rating to an “overweight” rating in a research report on Tuesday, August 26th. Two equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company has a consensus rating of “Buy”.
View Our Latest Report on DSRLF
DiaSorin Price Performance
About DiaSorin
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
Recommended Stories
- Five stocks we like better than DiaSorin
- How to Short Nasdaq: An Easy-to-Follow Guide
- Broadcom Stock Crashes 20%—But Wall Street Sees It Soaring to $500
- What is diluted earnings per share (Diluted EPS)?
- Forget the Chips: 4 Industrial Plays for the AI Rebound
- Options Trading – Understanding Strike Price
- MongoDB Could Hit Record Highs—But You’ll Need to Move Fast
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.
